Metabolomics Uncovers Biomarkers for PCOS Diagnosis and Therapy – JMSACL
JMSACL (Journal of Mass Spectrometry and Advances in the Clinical Lab) shared a post on LinkedIn:
“Source: (Journal of ovarian research)
Study on PCOS via mass spectrometry metabolomics identified 49 serum metabolites, with 39 upregulated and 10 downregulated. Key findings include altered lipid and amino acid metabolism, revealing candidate biomarkers for diagnosis and therapy. Metabolic pathways affected include sphingolipid metabolism.”
Title: Mass spectrometry-based untargeted metabolomics study of polycystic ovary syndrome
Authors: Ömer Faruk Özer, Ayşe Zeynep İbrahimoğlu, Ayşe Zehra Gül, Metin Demirel, Seda Ateş, Havva Sevde Taha, Merve İbrahimoğlu, Şahabettin Selek
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 14, 2025, 04:40Murat Levent Dereli: Monochorionic-Monoamniotic Twin with Aberrant Vascular Anastomosis
-
Dec 14, 2025, 04:18Impact of Basic Income on Health – The Center for Social Development at Washington University in St. Louis
-
Dec 14, 2025, 04:14Immune Regulation Insights from RaFJC Conference – Reproduction and Fertility
-
Dec 14, 2025, 04:07Jacques Maas: Transformative Strategies for Endometriosis and Adenomyosis
-
Dec 14, 2025, 04:04Caroline Ford: Reflects on a Journey in Gynaecological Cancer
-
Dec 14, 2025, 04:00Economic Impact of Endometriosis in New Zealand Revealed – Endometriosis New Zealand
-
Dec 14, 2025, 03:57Lone Hummelshoj: Exploring Experimental Models in Endometriosis and Adenomyosis
-
Dec 13, 2025, 04:22Placenta-Targeted Nanoparticles: A New Frontier in Recurrent Pregnancy Loss – Reproduction and Fertility
-
Dec 13, 2025, 03:57Yasmine Candau: I Was Once Only a Patient, Today I Put My Experience at the Service of Others